Ali Sié
Ali Sié, MD, PhD is an expert in Infectiology at University Hospital Heidelberg (Germany). As of October 2026, ScienceLeadR ranks Ali Sié in the top 1% of experts worldwide for Gastric Outlet Obstruction. Ali Sié has authored 357 publications, the most recent in 2026, and is an investigator in 21 clinical trials, 4 of them ongoing. SLR score: 1,236 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Public Health - Pediatrics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Dr Ali Sié, MD, PhD is a Burkinian epidemiology and and public health senior scientist and team leader of “Disease Control” at the Nouna Health Research Centre (CRSN). The latter is one of the major research centre of the National Institute of Public Health of Burkina Faso whose main objective is the provision of scientific evidence to health planners and policy makers for better health interventions. His main research area is clinical epidemiology of infectious diseases and health system research mainly focused on system performance. In recent years, he has growing interest on climate change and health issue in Burkina Faso, focusing on climate impact evaluation and adaptation strategies for local communities.
He was the leader of the climate change and health Working group at INDEPTH Network between 2010-2017 and is now leading the climate change and chronic diseases program at the National institute of public health in Burkina Faso. Till today, his long-standing public health and climate change and health research at CRSN have been consolidated and several communities, health related climate change research projects have been successfully conducted or continue to be implemented in collaboration with researchers worldwide.
He has been Principal Investigator and Co-Investigator of several clinical/field interventions trials and authored/co-authored more than 200 papers in peer reviewed journals (0000-0002-3959-2520) and sit in many scientific and managerial Boards.
Organizations
Career arc: 2007 - 2026
Number : 357
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 21
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Mother Screening for Relapse Using Mid upper Arm Circumference Among Children Recovered From Severe Acute Malnutrition (Full Scale Trial) NCT06599580 — research design, hemoglobins, mothers, malnutrition, anemia, infant nutrition disorders, caregivers, recycling, severe acute malnutrition, aged, child nutrition disorders, nutrition disorders, child, infant | N/A | Recruiting | 2025 |
| Azithromycin as Adjunctive Treatment for Uncomplicated Severe Acute Malnutrition NCT06010719 — mortality, malnutrition, suspensions, amoxicillin, severe acute malnutrition, azithromycin, therapeutics, child nutrition disorders, nutrition disorders, infections, child | Phase 4 | Recruiting | 2024 |
| Vitality in Infants Via Azithromycin for Neonates Trial NCT05763693 — mortality, growth, parturition, infant, newborn, malnutrition, infant mortality, aged, birth weight, azithromycin, communicable diseases, perinatal death, pyloric stenosis, hypertrophic, child, infant | Phase 4 | Not yet recruiting | 2026 |
| Infant Mortality Reduction by the Mass Administration of Azithromycin NCT04716712 — mortality, mass drug administration, infant mortality, pharmaceutical preparations, child mortality, azithromycin, macrolides, infections, child, infant, taste | Phase 4 | Active not recruiting | 2021 |
LeadR Networks
Main global connection map